BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)

Go back to BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)
(NASDAQ: FDMT) Delayed: 11.65 -0.22 (1.85%)
Previous Close $11.87    52 Week High
Open $11.93    52 Week Low
Day High $12.05    P/E N/A 
Day Low $11.34    EPS
Volume 705,822